How High Is the Bar for Future ALS Treatments? Although Neurologists Express Frustration with ...

Exton, Pennsylvania, Aug. 02, 2023 (GLOBE NEWSWIRE) -- A quiet but significant advance was made during the last year: not one, but two medicines were FDA approved to delay disease

Related Keywords

Pennsylvania ,United States ,Amylyx Relyvrio ,Linkedin ,Spherix Network ,Twitter ,Dynamix ,Amyotrophic Lateral Sclerosis ,Spherix Global Insight ,Market Dynamix ,Launch Dynamix ,Spherix Global Insights ,Global Insights ,Neurology Franchise Head Spherix Global Insights ,Region ,